Conversely, in another study, overexpression of IDH1 in glioma IDH-wildtype did not cause changes in the cell cycle, apoptosis, and invasion ability; however, it did result in chemotherapy resistance to TMZ in vivo and in vitro [25]. The gene discussed is IDH1; the disease is central nervous system cancer.